News and Opinions

By Anna MacDonald and Sarah Whelan - Technology Networks Cell and gene therapy is a field of personalized medicine, driving the innovation of medicine and revolutionizing the way we treat disease. Gene therapies use DNA or other genetic material to edit a patient's...

by Margarida Maia, PhD - Parkinson's News Today A request to launch a first Phase 1/2 clinical trial of a stem cell-based therapy in people with Parkinson’s disease has been approved by the Swedish Medical Products Agency. The therapy, called STEM-PD, consists of stem...

by Nature Italy By studying how hematopoietic stem cells respond to age and damage, Raffaella di Micco aims to anticipate the long-term effects of some gene therapies. This is a scene from my daily routine in my lab in Milan where we study hematopoietic stem cells,...

By The Ottawa Hospital - The Globe and Mail Treatment developed at The Ottawa Hospital can halt MS progression and potentially reverse symptoms When Geneviève Bétournay developed blurry vision and pain in her hips 12 years ago, she was shocked to be diagnosed with...

By Medical News Life Sciences Researchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have used CRISPR/Cas9 technology to engineer donor T cells to try to treat seriously ill children with...

By Genetic Engineering & Biotechnology News A study by scientists at the Icahn School of Medicine at Mount Sinai, the James J. Peters Veterans Affairs Medical Center, the Yale School of Medicine, and the New York Stem Cell Foundation Research Institute (NYSCF) has...

By Frances Stead Sellers - The Washington Post For the burgeoning population of covid long-haulers, there is an abundance of new treatment options: Specially formulated nutraceuticals imported from India that promise to “get you life back from covid.” Pure oxygen...

by By Beth JoJack - Medical News Today For the first time, researchers have used CRISPR gene-editing technology to substitute a gene in a patient’s immune cells to redirect those cells to fight cancer. Details of a small human clinical trial using this approach are...

By Lei Lei Wu - EndpointsNews MIT scientists have developed a tool that they say can insert large gene sequences where they want in the genome. In a paper published Thursday in Nature Biotechnology, MIT fellows Omar Abudayyeh, Jonathan Gootenberg and colleagues detail...

By Sulagna Ghosh, Ralda Nehme & Lindy E. Barrett Nature Communications While there are a growing number of human pluripotent stem cell repositories, genetic diversity remains limited in most collections and studies. Here, we discuss the importance of incorporating...

By Max Delbrook Center A big step toward producing rhino gametes To save the northern white rhinoceros from extinction, the BioRescue team is racing to create lab-grown egg and sperm cells of the critically endangered subspecies. The team has now reported a milestone...

by Bob Yirka , Phys.org A team of researchers at the University of California, Berkeley, and University of California, Los Angeles, working with a colleague from Vilnius University, has found evidence of thousands of phages with DNA strands that should allow them to...

By Megan Molteni - Stat News He Jiankui, the Chinese biophysicist who created the first gene-edited children, had been quiet since completing a three-year prison sentence in April, leaving many to wonder whether he had plans to return to scientific research. Earlier...

By Penn Today Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies. Engineered immune cells, known as CAR T cells, have shown the world what personalized...

by Rameesha Sajwar - Wonderful Engineering Gene-editing technology CRISPR has been used to remove genes from immune system cells to make them better at fighting cancer. Recently, PACT Pharma and UCLA have used CRISPR to remove and add genes to these cells to help them...

CIRM-funded USC+CHLA Alpha Clinic boosts capacity for clinical and translational research, community outreach, training and manufacturing By Wayne Lewis - Keck School of Medicine of USC The California Institute for Regenerative Medicine (CIRM), the state’s stem cell...

by Kelsey A. Rankin, Alison Mosier-Mills, Walter Hsiang & Daniel H. Wiznia - BMC Archives of Public Health Abstract Secret shopper studies are particularly potent study designs that allow for the gathering of objective data for a variety of research hypotheses,...

by by Kerstin Wagner, Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI) - Phys.org Image: Hematopoietic stem cells age very heterogeneously. The TAZ protein, a co-activator of the Hippo signaling pathway, can protect blood stem cells from...

by Takahiro Tanimoto, Kentaro Endo, Yuriko Sakamaki, Nobutake Ozeki, Hisako Katano, Mitsuru Mizuno, Hideyuki Koga & Ichiro Sekiya - Scientific Reports Abstract The possibility that mesenchymal stem cells (MSCs) can adhere to partial defects or degenerative areas...

By By Cade Hildreth, BioInformant Palo Alto, CA – Greenstone Biosciences, Inc. (“Greenstone Bio”), a commercial-stage computational biology company, announces that the Company has received a DISC0 grant funding from the California Institute of Regenerative Medicine...